Jim Johnson

ID: 1b8379ff-2619-30fb-68c4

/

Unclaimed

/

Organization: Hogan Lovells

FDA to Rely on Drug Inspections Performed by Certain European Regulatory Authorities Beginning November 1, 2017

Focus on Regulation · October 31, 2017

FDA Launches New Tool For Accessing Drug Adverse Event Information

Focus on Regulation · October 4, 2017

Continuing Coverage of FDA’s Crackdown on Stem Cell Clinics: Florida Clinic Cited for Unapproved Marketing and Inadequate Sterility Assurance

Focus on Regulation · September 20, 2017

FDA Seizes Stem Cell Therapy—A First of Many?

Focus on Regulation · August 29, 2017

FDA, EU Regulators Agree to Share Unredacted Inspection Reports and Other Confidential Information

Focus on Regulation · August 25, 2017